sever
acut
respiratori
syndrom
coronaviru
sarscov
caus
lethal
diseas
human
character
exacerb
inflammatori
respons
extens
lung
patholog
address
relev
small
noncod
rna
sarscov
patholog
deep
sequenc
rna
lung
infect
mice
discov
three
nt
small
viral
rna
svrna
three
svrna
deriv
n
svrnan
genom
region
sarscov
biogenesi
cov
svrna
rnase
iii
cell
type
host
speci
independ
depend
extent
viral
replic
antagomirmedi
inhibit
svrnan
significantli
reduc
vivo
lung
patholog
proinflammatori
cytokin
express
taken
togeth
data
indic
svrna
contribut
sarscov
pathogenesi
highlight
potenti
svrnan
antagomir
antivir
sever
acut
respiratori
syndrom
coronaviru
sarscov
emerg
china
spread
countri
infect
around
peopl
caus
mortal
young
peopl
elderli
perlman
netland
bat
identifi
zoonot
primari
reservoir
sarscovassoci
coronavirus
cov
perlman
netland
transmit
viru
human
either
directli
intermedi
host
global
distribut
bat
increas
probabl
futur
emerg
pathogen
human
cov
date
vaccin
antivir
approv
either
sarscov
emerg
cov
middl
east
respiratori
syndrom
cov
merscov
understand
molecular
mechan
viral
pathogenesi
aid
search
effect
safe
therapeut
strategi
known
human
cov
new
emerg
strain
sarscov
encod
small
transmembran
envelop
e
protein
particip
viral
morphogenesi
contribut
exacerb
inflammatori
respons
associ
acut
respiratori
distress
syndrom
ard
engin
mutant
lack
e
protein
attenu
vivo
caus
diminish
inflammatori
patholog
lung
increas
surviv
dediego
et
al
therefor
e
protein
virul
factor
contribut
sarscov
pathogenesi
differ
mechan
action
includ
nfkb
activ
inflammasom
activ
ion
channel
activ
mitogenactiv
protein
kinas
mapk
activ
pdzbind
motif
interact
cellular
protein
syntenin
induc
express
proinflammatori
cytokin
addit
protein
compon
viral
genom
also
encod
noncod
rna
ncrna
differ
size
biogenesi
function
necessarili
compar
produc
host
cell
tycowski
et
al
wide
accept
dna
virus
cullen
rna
virus
nuclear
stage
retrovirus
tycowski
et
al
encod
ncrna
form
microrna
mirna
small
ncrna
found
eukaryot
cell
serv
finetun
host
transcriptom
sequencespecif
manner
bartel
document
virusencod
mirna
appear
involv
establish
persist
tenoev
addit
virusencod
mirna
increas
sensit
deep
sequenc
technolog
also
made
possibl
detect
small
viral
ncrna
gener
cytoplasm
rna
virus
parameswaran
et
al
perez
et
al
shapiro
et
al
weng
et
al
nuclear
virus
use
canon
mirna
biogenesi
pathway
grundhoff
sullivan
rna
virus
induc
variou
altern
cytoplasm
pathway
includ
cellular
viral
factor
express
ncrna
bidet
et
al
perez
et
al
demonstr
excis
engin
ncrna
viral
rna
genom
result
signific
genom
cleavag
tenoev
selfinduc
posttranscript
gene
silenc
virusderiv
ncrna
function
relev
regul
viral
life
cycl
demonstr
influenza
viru
enteroviru
weng
et
al
also
pathogenesi
shown
small
flaviviru
rna
bidet
et
al
robi
et
al
grow
evid
support
express
small
ncrna
rna
virus
want
address
question
whether
sarscov
also
gener
small
ncrna
infect
explor
relev
viral
small
ncrna
pathogenesi
sarscov
mous
model
infect
dediego
et
al
robert
et
al
deep
sequenc
analysi
small
rna
lung
reveal
small
rna
sarscov
genom
three
nt
small
viral
rna
svrna
deriv
n
svrnan
genom
region
sarscov
character
biogenesi
svrna
infect
rnase
iii
independ
modestli
impact
viral
titer
vitro
remark
deplet
svrnan
vivo
significantli
reduc
lung
patholog
express
proinflammatori
cytokin
support
svrna
contribut
sarscov
pathogenesi
address
relev
small
ncrna
sarscov
pathogenesi
infect
balbc
mice
either
mouseadapt
virul
recapitul
infect
human
includ
sever
lung
diseas
mortalityor
attenu
caus
mild
lung
inflamm
dediego
et
al
small
rna
mous
lung
tissu
day
postinfect
dpi
deep
sequenc
approxim
qualityfilt
small
rna
sequenc
map
mous
genom
tabl
correspond
differ
class
small
cellular
rna
includ
mirna
previous
observ
peng
et
al
interestingli
small
rna
sequenc
align
specif
sarscov
genom
identifi
dpi
lung
mice
infect
virul
attenu
residu
read
detect
mockinfect
lung
correspond
deep
sequenc
background
tabl
sequenc
align
sarscov
genom
repres
less
small
rna
similar
abund
report
infect
rna
virus
parameswaran
et
al
perez
et
al
also
sarscov
peng
et
al
differ
number
read
virul
attenu
sarscov
dpi
demonstr
similar
pattern
infecti
viral
titer
lung
figur
lung
sampl
mice
infect
virul
viru
show
highest
number
sarscovderiv
read
viral
titer
dpi
larg
proport
svrna
map
positivestrand
genom
rna
tabl
distribut
across
entir
viral
genom
expect
viral
breakdown
product
enrich
end
genom
figur
contrast
limit
number
peak
correspond
abund
svrna
map
specif
genom
posit
also
observ
tabl
particular
viral
sequenc
enrich
three
svrna
tabl
align
specif
genom
region
virul
attenu
sarscov
figur
select
function
studi
svrna
posit
sens
nt
length
map
end
replicas
gene
n
gene
svrnan
end
genom
rna
grna
total
read
three
svrna
tabl
highest
number
correspond
infect
dpi
also
show
highest
viral
titer
figur
share
first
nt
sequenc
align
close
posit
grna
respect
figur
tabl
correspond
end
glurich
acid
hypervari
domain
sequenc
respect
contrast
read
detect
nearbi
region
nt
select
neg
control
experi
svrnaneg
presenc
three
svrna
absenc
svrnaneg
lung
sampl
confirm
specif
small
rna
rtqpcr
assay
figur
furthermor
svrna
detect
differ
extent
serum
mice
figur
abund
small
rna
infect
dpi
although
number
svrnan
read
infect
lung
similar
figur
tabl
serum
level
svrnan
almost
mockinfect
mice
suggest
might
stabl
svrnan
serum
kinet
product
sarscovderiv
small
rna
studi
differ
mammalian
cell
line
suscept
infect
human
lung
epitheli
cell
n
detect
rtqpcr
low
level
agreement
lower
viral
titer
obtain
cell
line
figur
contrast
mous
cell
three
svrna
accumul
high
level
fold
increas
compar
mockinfect
cell
expect
minim
amount
svrnaneg
detect
figur
direct
correl
observ
abund
svrna
gener
infect
infecti
viral
titer
intracellular
grna
amount
figur
level
increas
hr
postinfect
hpi
maximum
hpi
moreov
attenu
mutant
defect
e
protein
ion
channel
activ
grow
effici
wildtyp
wt
viru
figur
produc
cell
similar
level
wt
n
figur
result
suggest
gener
n
cell
speci
specif
depend
extent
viral
replic
address
biolog
function
sarscov
infect
inhibit
svrna
transfect
cell
specif
antisvrna
oligonucleotid
hr
prior
viru
infect
specif
inhibit
svrna
infect
analyz
rtqpcr
figur
amount
svrnan
significantli
reduc
level
cell
transfect
nonrel
sequenc
inhibitor
nrrna
differ
time
point
level
progress
reduc
time
although
lesser
extent
amount
seen
nrrnatransfect
cell
contrast
transfect
differ
amount
specif
inhibitor
fail
reduc
level
result
may
mislead
sinc
sequencedepend
interfer
among
small
rna
antisens
oligonucleotid
qpcr
assay
report
lead
fals
posit
result
torr
et
al
therefor
function
assay
requir
confirm
svrna
repress
transfect
increas
dose
svrnan
inhibitor
result
dosedepend
reduct
svrnan
level
confirm
specif
inhibit
svrnan
figur
inhibit
antisvrna
infect
signific
impact
level
n
protein
figur
viral
titer
supernat
modestli
reduc
depend
time
postinfect
svrna
speci
figur
inhibit
svrnan
led
signific
reduct
comparison
nrrna
control
inhibitor
log
unit
decreas
viral
titer
hpi
wherea
inhibit
caus
less
signific
reduct
time
point
result
suggest
product
svrna
infect
posit
although
modest
effect
sarscov
growth
determin
whether
svrna
process
cell
mirna
machineri
absenc
infect
includ
nt
sequenc
flank
svrna
sarscov
genom
potenti
mirna
precursor
within
intron
sequenc
report
plasmid
process
viral
small
rna
plasmid
detect
figur
suggest
svrna
gener
depend
viral
factor
cell
protein
induc
viru
infect
explor
whether
svrna
gener
sarscov
infect
canon
pathway
mirna
biogenesi
analyz
svrna
product
absenc
two
mammalian
rnase
iii
nucleas
drosha
dicer
respons
mirna
process
rnase
iiidefici
cell
benitez
et
al
made
suscept
sarscov
transient
express
murin
receptor
reglanava
et
al
sarscov
grna
level
rnase
iiidefici
cell
similar
viral
titer
slightli
lower
absenc
rnase
iii
nucleas
figur
suggest
cellular
enzym
essenti
viral
replic
moreov
biogenesi
svrna
overtli
impair
absenc
dicer
drosha
suggest
mirna
biogenesi
pathway
respons
synthesi
noncanon
figur
determin
whether
svrna
encod
sarscov
could
infer
posttranscript
silenc
akin
cellular
mirna
clone
complementari
sequenc
svrna
utr
luciferas
report
gene
whose
activ
measur
presenc
absenc
svrna
first
approach
cell
transfect
oligonucleotid
mimick
svrnan
nrrna
along
appropri
luciferas
plasmid
absenc
infect
figur
three
svrna
mimic
repress
luciferas
express
activ
measur
presenc
nrrna
neg
control
repress
effici
similar
observ
mimic
cellular
use
posit
control
addit
cotransfect
inhibitor
oligonucleotid
antisens
sequenc
partial
total
svrnan
restor
luciferas
activ
contrast
cotransfect
inhibitor
nonrel
sequenc
affect
inhibit
luciferas
express
svrna
result
confirm
potenti
n
specif
bind
target
sequenc
utr
mrna
neg
regul
express
inhibit
target
mrna
express
svrna
gener
context
infect
would
requir
cellular
rna
interfer
rnai
machineri
remain
function
sarscov
infect
confirm
activ
transfect
precursor
cellular
along
luciferas
report
plasmid
contain
target
sequenc
mrna
utr
process
precursor
sequenc
effici
repress
express
luciferas
less
control
mock
infect
cell
figur
confirm
sarscov
infect
inhibit
cellular
rnai
machineri
cell
hpi
assess
regulatori
effect
svrna
infect
transfect
sarscovinfect
cell
plasmid
encod
luciferas
mrna
contain
target
sequenc
svrna
utr
figur
virusderiv
svrnan
significantli
silenc
luciferas
express
compar
mockinfect
cell
although
lower
extent
svrnan
mimic
transfect
absenc
infect
figur
result
suggest
although
svrna
per
se
abl
silenc
mrna
express
context
infect
may
limit
access
mrna
target
transfect
plasmid
either
locat
differ
subcellular
compart
viral
virusinduc
cellular
factor
competit
inhibit
interact
svrnan
demonstr
abil
regul
sarscov
growth
figur
repress
express
target
mrna
even
context
infect
murin
cell
figur
select
svrna
assess
biolog
effect
mice
relev
system
studi
potenti
virushost
interact
grundhoff
sullivan
determin
role
svrnan
pathogenesi
use
small
synthet
rna
molecul
perfectli
complementari
specif
svrna
antagomir
inhibit
svrnan
vivo
sarscov
infect
balbc
mice
intranas
inocul
singl
dose
lock
nucleic
acid
lna
correspond
either
antisvrnan
neg
control
inhibitor
antinrrna
hr
prior
infect
lna
use
vivo
includ
chemic
modif
increas
stabil
inhibitori
efficaci
minim
offtarget
immunostimulatori
effect
experiment
procedur
advers
effect
weight
loss
movement
difficulti
lethargi
unhealthi
appear
observ
mice
administr
lna
day
followup
experi
signific
last
reduct
svrnan
level
nonspecif
inhibitor
control
observ
rtqpcr
dpi
figur
mockinfect
anim
treat
either
svrnan
inhibitor
neg
control
antinrrna
lose
weight
throughout
experi
inhibit
svrnan
sarscovinfect
mice
enough
prevent
weight
loss
howev
modest
although
sustain
reduct
weight
loss
observ
mice
treat
antisvrnan
compar
treat
antinrrna
day
period
follow
infect
figur
svrnan
inhibit
led
moder
reduct
level
viral
grna
subgenom
mrna
sgmrna
n
dpi
figur
signific
effect
lung
viral
titer
time
observ
figur
suggest
svrnan
limit
effect
viral
replic
vivo
lung
patholog
examin
dpi
score
sever
scale
indic
percentag
affect
area
hemorrhag
pulmonari
consolid
gralinski
et
al
evid
gross
lesion
observ
mockinfect
lung
importantli
svrnan
inhibit
led
signific
reduct
gross
patholog
figur
contrast
lung
mice
treat
neg
control
lna
show
extens
hemorrhag
area
especi
dpi
character
pulmonari
histopatholog
sarscovinfect
mice
treat
svrnan
inhibitor
collect
lung
section
dpi
stain
hematoxylin
eosin
h
e
figur
patholog
featur
pulmonari
inflamm
score
previous
describ
figur
pronounc
inflammatori
cell
infiltr
edema
observ
alveolar
bronchiolar
airway
mice
treat
neg
control
lna
contrast
treatment
antisvrnan
significantli
reduc
inflamm
keep
alveolar
space
free
anda
consequencealso
improv
anim
welfar
sarscov
infect
induc
high
level
proinflammatori
cytokin
contribut
lung
immunopatholog
promot
sarscov
morbid
mortal
channappanavar
et
al
dediego
et
al
studi
whether
treatment
antisvrnan
lna
affect
product
proinflammatori
cytokin
lung
analyz
express
sever
gene
previous
associ
sarscov
patholog
includ
signific
decreas
mrna
express
level
observ
mice
treat
svrnan
inhibitor
figur
agreement
observ
reduct
lung
patholog
moreov
inhibit
svrnan
significantli
increas
express
antivir
interferon
ifn
stimul
gene
contrast
signific
effect
observ
indic
specif
effect
svrnan
express
proinflammatori
cytokin
sinc
inhibit
svrnan
affect
viral
titer
lung
figur
observ
decreas
inflamm
attribut
reduct
viral
growth
overal
result
show
contribut
svrna
inflammatori
lung
patholog
induc
sarscov
infect
address
question
tissu
specif
svrnan
action
perform
immunohistochemistri
stain
infect
lung
tissu
day
postinfect
lung
mice
treat
svrnan
inhibitor
show
stain
sarscov
bronchiolar
airway
lung
parenchyma
similar
tissu
distribut
observ
anim
treat
neg
control
inhibitor
figur
result
confirm
inhibit
svrnan
reduc
inflammatori
cell
infiltr
edema
lung
signific
effect
tissu
specif
sarscov
infect
studi
relev
sarscov
pathogenesi
small
ncrna
deriv
viral
genom
small
rna
analyz
deep
sequenc
lung
balbc
mice
reproduc
sever
pulmonari
diseas
observ
human
sarscov
epidem
sinc
ncrna
cell
specif
expect
vivo
approach
provid
biolog
relev
result
term
contribut
virushost
interact
cox
sullivan
analysi
result
discoveri
small
rna
deriv
sarscov
grow
evid
support
gener
small
ncrna
rna
virus
describ
influenza
viru
weng
et
al
hepat
viru
hav
shi
et
al
hcv
polio
dengu
vesicular
stomat
west
nile
virus
parameswaran
et
al
describ
rna
virus
hav
shi
et
al
influenza
svrna
repres
minor
proport
total
small
rna
sequenc
obtain
infect
tissu
although
low
abund
compat
relev
biolog
function
current
work
abund
sarscovderiv
svrna
correl
viral
titer
observ
sever
experiment
system
figur
furthermor
observ
rna
virus
vast
major
sarscov
svrna
sequenc
posit
sens
viral
genom
parameswaran
et
al
shi
et
al
svrna
evenli
distribut
throughout
sarscov
genom
suggest
product
hotspot
locat
preferenti
near
genom
end
pattern
also
observ
influenza
viru
argu
svrna
mere
viral
degrad
product
activ
gener
play
role
infect
perez
et
al
three
abund
svrna
repres
total
viral
sequenc
align
sarscov
genom
region
express
differ
level
infect
two
gener
genom
region
code
glurich
acid
domain
one
nonstructur
protein
produc
proteolyt
process
replicas
polyprotein
largest
replicas
subunit
aa
multidomain
structur
includ
transmembran
domain
papainelik
proteas
domain
nucleicacid
bind
domain
ubiquitinlik
domain
glurich
acid
domain
domain
adrp
macrodomain
x
domain
sarsuniqu
domain
sud
et
al
neuman
et
al
svrna
map
end
glurich
acid
hypervari
code
region
respect
domain
involv
interact
singlestrand
rna
replicas
gene
express
lower
level
genom
region
present
collect
cotermin
sgmrna
gener
discontinu
transcript
enjuan
et
al
svrnan
deriv
n
gene
locat
end
genom
express
significantli
higher
level
background
surround
viral
sequenc
coronaviru
nucleoprotein
n
essenti
format
virion
structur
also
rna
synthesi
shown
cov
n
protein
rna
chaperon
activ
requir
effici
discontinu
transcript
subgenom
rna
et
al
svrnan
map
n
genestructur
region
code
rnabind
domain
locat
n
terminu
protein
preced
disord
central
region
share
first
nt
sequenc
sequenc
repeat
three
time
sarscov
genom
posit
within
region
code
glurich
domain
deriv
genom
sequenc
start
nt
sequenc
nt
produc
signific
number
read
relev
repeat
garich
motif
gener
svrna
would
requir
investig
high
level
also
detect
serum
infect
mice
n
present
signific
level
despit
similar
abund
lung
observ
may
reflect
rel
stabil
altern
may
suggest
may
activ
transport
blood
presenc
serum
common
wt
infect
suggest
mechan
respons
specif
transport
blood
depend
e
protein
activ
three
sarscov
svrna
deriv
code
region
genom
observ
rna
virus
hav
shi
et
al
contrast
svrna
influenza
viru
deriv
noncod
region
segment
theoret
argument
svrna
deriv
cytoplasm
rna
virus
excis
deleteri
viral
genom
integr
cullen
howev
cytoplasm
virus
engin
produc
function
mirna
genom
signific
impact
viral
growth
bidet
et
al
varbl
et
al
weng
et
al
shapiro
et
al
result
show
inhibit
antisvrna
infect
signific
impact
level
n
protein
suggest
import
loss
genom
materi
interfer
replic
machineri
induc
consequ
svrna
product
svrna
perfectli
complementari
negativesens
replic
intermedi
rna
might
selfsilenc
target
howev
svrna
inhibit
increas
express
viral
protein
n
viral
titer
suggest
svrna
relev
genesilenc
activ
negativesens
sarscov
rna
result
support
biogenesi
sarscov
svrna
mainli
independ
canon
cellular
pathway
depend
altern
mechan
involv
viral
protein
cellular
factor
induc
infect
sinc
matur
nt
svrna
speci
gener
noninfect
cell
plasmid
includ
viral
genom
sequenc
biogenesi
svrna
independ
mirna
process
enzym
dicer
drosha
result
suggest
biogenesi
may
requir
argonaut
case
cheloufi
et
al
gener
viral
nucleas
cov
replicas
encod
essenti
rnaprocess
enzym
found
rna
viru
famili
endoribonucleas
ricagno
et
al
might
involv
biogenesi
svrna
sarscov
genom
nucleolyt
activ
singleand
doublestrand
rna
although
specif
function
rna
synthesi
complet
understood
product
specif
small
viral
rna
viral
compon
demonstr
influenza
viru
altern
noncod
subgenom
flaviviru
rna
gener
cellular
exoribonucleas
partial
degrad
genom
rna
stall
secondari
rna
structur
utr
robi
et
al
although
number
exampl
svrna
express
rna
virus
still
limit
varieti
mechan
involv
biogenesi
function
gener
svrna
gener
genom
end
nearbi
region
weng
et
al
robi
et
al
sarscov
svrna
gener
intern
genom
region
although
rel
close
svrnan
end
consid
sarscov
one
largest
genom
around
nt
among
rna
virus
differ
genom
origin
svrna
sarscov
compar
rna
virus
might
explain
heterogen
biogenesi
mechan
action
regard
function
viral
ncrna
could
contribut
regul
viral
life
cycl
weng
et
al
inhibit
host
defens
viral
infect
ding
voinnet
lossoffunct
studi
sarscov
svrna
use
antisens
oligonucleotid
cell
show
signific
reduct
viru
titer
late
time
postinfect
svrnan
associ
reduct
svrna
level
suggest
svrna
relev
contribut
viru
replic
analyz
biolog
relev
sarscov
svrnan
studi
function
vivo
provid
physiolog
context
virushost
interact
includ
innat
immun
respons
rnamedi
regulatori
network
inhibit
svrnan
vivo
reduc
moder
accumul
grna
lung
infect
mice
dpi
signific
decreas
viral
titer
suggest
effect
svrnan
viral
replic
relev
remark
administr
antisvrnan
lna
prior
infect
sarscov
reduc
pulmonari
inflamm
product
proinflammatori
cytokin
mice
although
viral
titer
significantli
affect
moder
reduct
lung
damag
markerssuch
edema
cellular
infiltratesobserv
dpi
reduct
proinflammatori
cytokinessuch
contribut
svrna
inflammatori
lung
pathogenesi
moreov
inhibit
svrnan
increas
express
dpi
modul
host
respons
viral
infect
inhibit
svrnan
vivo
support
contribut
isg
lung
patholog
immunomodulatori
molecul
reduc
potenti
patholog
level
proinflammatori
molecul
rather
direct
antivir
effect
similarli
deplet
chikungunya
virusinfect
mice
shown
promot
increas
proinflammatori
cytokin
without
affect
viral
titer
wernek
et
al
svrnaninduc
reduct
inflammatori
patholog
associ
decreas
viral
titer
result
agreement
prior
observ
sarscovinfect
human
anim
indic
major
mechan
lung
pathogenesi
dysregul
excess
express
sever
proinflammatori
cytokin
chemokin
independ
extent
viru
replic
natur
minimum
threshold
viru
replic
achiev
nichol
et
al
channappanavar
et
al
et
al
nietotorr
et
al
infect
svrnan
may
act
via
cellular
factor
either
rnarna
interact
known
mirna
rnaprotein
interact
bidet
et
al
perez
et
al
sinc
svrnan
abl
silenc
express
target
mrna
report
figur
propos
might
contribut
lung
patholog
figur
regul
cellular
mrna
involv
host
inflammatori
respons
via
rnai
svrna
express
might
increas
inflamm
repress
express
factor
involv
downregul
host
inflammatori
respons
unfortun
current
knowledg
mechan
action
svrna
still
limit
inform
whether
bind
target
seed
sequenc
thu
repress
express
similarli
canon
mirna
make
bioinformat
predict
target
complex
object
genom
sequenc
mouseadapt
svrna
origin
conserv
human
sarscov
urbani
strain
sarsrel
bat
cov
includ
cpyunnan
isol
distant
cov
merscov
suggest
genu
specif
particular
svrnan
complet
conserv
sarsrel
bat
cov
therefor
infect
human
sarscov
would
also
expect
gener
svrna
ident
origin
provid
svrna
act
bind
complementari
sequenc
target
mrna
svrna
human
mouseadapt
sarscov
might
expect
regul
express
human
mous
mrna
similar
manner
sinc
mirna
target
utr
mammalian
mrna
preferenti
conserv
friedman
et
al
svrnan
inhibit
reduc
lung
patholog
caus
sarscov
antisvrnan
potenti
use
compound
antivir
therapi
although
suffici
increas
mice
surviv
possibl
dose
schedul
administr
lna
antisvrnan
need
optim
moreov
sarscov
includ
mani
virul
factor
e
protein
promot
inflamm
differ
mechan
attenu
mutant
defect
e
protein
ion
channel
activ
grew
effici
wt
viru
produc
similar
level
n
cell
assum
svrna
product
vivo
also
compar
virus
svrnan
might
contribut
limit
proinflammatori
respons
still
present
mice
compar
noninfect
mice
confirm
multipl
mechan
contribut
sarscov
lung
patholog
use
antagomir
antivir
sever
advantag
compar
strategi
high
specif
virusderiv
target
avoid
secondari
effect
action
cellular
target
abil
use
combin
antivir
therapi
increas
efficaci
safeti
fact
administr
human
promis
efficaci
reduc
hcv
rna
janssen
et
al
unravel
molecular
mechan
svrnan
contribut
lung
inflamm
aid
design
antivir
control
exacerb
host
respons
induc
sarscov
infect
mouseadapt
parent
sarscov
recombin
virus
rescu
infecti
cdna
clone
gener
bacteri
artifici
chromosom
bac
laboratori
dediego
et
al
nietotorr
et
al
cell
line
gener
maintain
describ
supplement
experiment
procedur
cell
defici
dicer
drosha
describ
elsewher
benitez
et
al
viru
titrat
perform
vero
cell
describ
supplement
experiment
procedur
femal
mice
intranas
inocul
pfu
rsarscovwt
svrnan
inhibit
experi
hr
prior
infect
mice
intranas
inocul
mgkg
inhibitor
mircuri
lna
microrna
inhibitor
exiqon
intranas
inocul
mice
lightli
anesthet
isofluran
solut
contain
either
svrna
inhibitor
hr
infect
viru
laid
nostril
mous
use
pipett
tip
small
droplet
natur
inhal
mous
later
sinc
procedur
noninvas
requir
relev
physic
intervent
caus
inflamm
mice
analyz
sarscov
titer
homogen
onequart
right
lung
ml
phosphatebuff
salin
pb
contain
uiml
penicillin
streptomycin
gentamicin
fungizon
use
mac
homogen
miltenyi
biotec
accord
manufactur
protocol
perform
viru
titrat
describ
supplement
experiment
procedur
isol
long
small
rna
separ
homogen
onehalf
right
lung
ml
lysisbind
solut
mirvana
mirna
isol
kit
ambion
use
mac
homogen
miltenyi
biotec
accord
manufactur
protocol
extract
rna
use
mirvana
mirna
isol
protocol
isol
small
rna
total
rna
sampl
examin
lung
histopatholog
fix
left
lung
infect
mice
zinc
formalin
hr
embed
paraffin
serial
longitudin
section
stain
h
e
histolog
servic
nation
center
biotechnolog
cnb
spain
subject
histopatholog
examin
zeiss
axiophot
fluoresc
microscop
sampl
obtain
use
systemat
uniform
random
procedur
consist
serial
parallel
slice
made
constant
thick
interv
histopatholog
analysi
conduct
blind
manner
acquir
imag
random
microscopi
field
around
nonadjac
section
three
independ
mice
analyz
per
treatment
group
measur
lung
damag
score
use
sever
scale
absent
sever
presenc
interstiti
peribronchiolar
perivascular
inflamm
describ
refer
web
version
pubm
central
supplementari
materi
sarscov
caus
exacerb
inflammatori
respons
extens
lung
patholog
lethal
diseas
human
moral
et
al
identifi
sarscovencod
small
viral
rna
svrna
express
lung
infect
viru
ngenederiv
svrna
svrnan
contribut
enhanc
lung
inflammatori
patholog
antisens
svrnan
inhibitor
significantli
reduc
pulmonari
inflamm
vivo
infect
mice
sarscov
small
viral
rna
svrna
identifi
infect
lung
cell
cultur
sarscov
svrna
biogenesi
rnase
iii
cell
type
speci
independ
svrnan
repress
express
mrna
utr
specif
target
sequenc
svrnan
inhibit
vivo
reduc
lung
patholog
proinflammatori
cytokin
c
rtqpcr
detect
svrnan
lung
c
serum
infect
mice
viral
sequenc
nt
read
detect
deep
sequenc
use
neg
control
svrnaneg
level
svrna
relat
mockinfect
sampl
calcul
method
use
spike
refer
endogen
gene
lung
serum
sampl
respect
data
express
mean
error
bar
repres
sd
see
also
tabl
rtqpcr
quantif
svrna
level
hpi
indic
figur
b
rtqpcr
quantif
sarscov
genom
rna
viral
titer
grna
level
relat
mockinfect
cell
calcul
method
use
rrna
refer
endogen
gene
viral
titer
measur
supernat
infect
cell
c
inhibit
sarscovderiv
svrna
rna
inhibitor
transfect
cell
hr
infect
moi
nonrel
rna
nrrna
use
control
c
svrna
level
determin
qpcr
indic
percentag
cell
transfect
nrrna
method
use
rel
quantif
endogen
control
viral
titer
svrna
inhibit
data
express
mean
error
bar
repres
sd
p
valu
see
also
figur
balbc
mice
intranas
inocul
mgkg
lna
svrnan
inhibitor
nonrel
sequenc
nrrna
neg
control
hr
mice
infect
pfu
sarscov
lung
collect
dpi
rtqpcr
analysi
svrnan
rel
express
lung
indic
percentag
express
mice
inocul
nrrna
method
use
rel
quantif
describ
figur
p
valu
averag
number
three
biolog
replic
three
svrna
read
express
percentag
total
read
align
viral
genom
indic
bottom
row
experiment
condit
cell
host
microb
author
manuscript
avail
pmc
octob
